ACTIVE LEARNING TEMPLATE: Medication
Kendra Heath
STUDENT NAME _____________________________________
Amlodipine (Norvasc)
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
antihypertensives, calcium channel blockers
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
Inhibits the transport of calcium into Systemic vasodilation resulting in decreased
myocardial and vascular smooth muscle cells BP
Complications Medication Administration
Dizziness, fatigue 5-10 mg once a day
Peripheral edema, angina, bradycardia, hypotension 2.5 mg a day(if pt is fragile or
Gungival hyperplasia, nausea
small)
Flushing
Contraindications/Precautions
Hypersensitvity, Systolic BP
Nursing Interventions
Monitor BP and pulse before
therapy
Monitor intake and output ratios
and daily weight
Monitor frequency of
Interactions prescription refills to determine
Strong CYP3A4 inhibitors, including ketoconazole, adherence
itraconazole, clarithromycin, and ritonavir may rise levels.
Client Education
Advise pt to take medication as
directed
Evaluation of Medication Effectiveness Caution pt to change positions
Decrease in BP slowly
Decrease in frequency and severity of anginal attacks Hypertension
Decrease in need for nitrate therapy Instruct pt on concurrent nitrate
Increase in activity tolerance and sense of well-being.
ACTIVE LEARNING TEMPLATES THERAPEUTIC PROCEDURE A7
Kendra Heath
STUDENT NAME _____________________________________
Amlodipine (Norvasc)
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
antihypertensives, calcium channel blockers
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
Inhibits the transport of calcium into Systemic vasodilation resulting in decreased
myocardial and vascular smooth muscle cells BP
Complications Medication Administration
Dizziness, fatigue 5-10 mg once a day
Peripheral edema, angina, bradycardia, hypotension 2.5 mg a day(if pt is fragile or
Gungival hyperplasia, nausea
small)
Flushing
Contraindications/Precautions
Hypersensitvity, Systolic BP
Nursing Interventions
Monitor BP and pulse before
therapy
Monitor intake and output ratios
and daily weight
Monitor frequency of
Interactions prescription refills to determine
Strong CYP3A4 inhibitors, including ketoconazole, adherence
itraconazole, clarithromycin, and ritonavir may rise levels.
Client Education
Advise pt to take medication as
directed
Evaluation of Medication Effectiveness Caution pt to change positions
Decrease in BP slowly
Decrease in frequency and severity of anginal attacks Hypertension
Decrease in need for nitrate therapy Instruct pt on concurrent nitrate
Increase in activity tolerance and sense of well-being.
ACTIVE LEARNING TEMPLATES THERAPEUTIC PROCEDURE A7
